← All organizations

Jiangsu Gensciences lnc.

For profit

Also known as: Haimen Gensciences lnc | Jiangsu Gensciences lnc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2023

Timeline

2020s

Jun 1, 2020
Jiangsu Gensciences lnc.— Founded

Drugs by trial phase (3 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

antihemophilic factor viii (Recombinant), Fc-fusion protein

Phase 2 (1 own, 0 via acquisition)

ss109

Phase 1 (1 own, 0 via acquisition)

antihemophilic factor viii (Recombinant)

Indications

Studied for

Hemophilia A

Recent trials (9)

NCT06142552Lead sponsorPhase 3Nov 30, 2023
NCT06136507Lead sponsorPhase 3Nov 25, 2023
NCT06010953Lead sponsorPhase 1/Phase 2Oct 12, 2023
NCT05651061Lead sponsorPhase 1Dec 5, 2022
NCT05251090Lead sponsorPhase 1Apr 30, 2022
NCT05265286Lead sponsorPhase 2Apr 14, 2022
NCT04864743Lead sponsorPhase 1Jun 22, 2021
NCT04845399CollaboratorPhase 3Apr 16, 2021
NCT04456387CollaboratorPhase 3Oct 15, 2020

Details

Founded: Jiangsu, CN Jun 1, 2020
Last known activity: Nov 30, 2023